Showing results (331-340 of 466) with videos related to
Sort By:
Pageof 47
Haematologica|August 4, 2009
Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionBella Patel, Keiren E Kirkland, Richard Szydlo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.Bone Marrow Transplantation|January 14, 2009
Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithmsB E Shaw, P Veys, A Pagliuca, et al.Bone Marrow Transplantation|January 17, 2017
Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplantsB E Shaw, N P Mayor, R M Szydlo, et al.Mycoses|August 27, 2016
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplantCarlos Solano, Monica Slavin, Alissa J Shaul, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 14, 2020
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular TherapyAbraham S Kanate, Navneet S Majhail, Bipin N Savani, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 11, 2015
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow TransplantationNavneet S Majhail, Stephanie H Farnia, Paul A Carpenter, et al.Trials|October 16, 2015
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trialClaire M Rice, David I Marks, Yoav Ben-Shlomo, et al.The Lancet. Oncology|June 19, 2010
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisMary Eapen, Vanderson Rocha, Guillermo Sanz, et al.Blood|October 18, 2002
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantationDavid I Marks, Richard Lush, Jamie Cavenagh, et al.Pageof 47